Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C44H55NO16 |
Molecular Weight | 853.9046 |
Optical Activity | ( - ) |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](OC(=O)CC)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CO6
InChI
InChIKey=XIVMHSNIQAICTR-UQYHODNASA-N
InChI=1S/C44H55NO16/c1-10-29(47)58-27-19-28-43(21-56-28,60-23(3)46)34-36(59-37(51)24-15-12-11-13-16-24)44(54)20-26(22(2)30(41(44,7)8)32(48)35(50)42(27,34)9)57-38(52)33(49)31(25-17-14-18-55-25)45-39(53)61-40(4,5)6/h11-18,26-28,31-34,36,48-49,54H,10,19-21H2,1-9H3,(H,45,53)/t26-,27-,28+,31-,32+,33+,34-,36-,42+,43-,44+/m0/s1
Milataxel, a taxane that binds to and stabilizes tubulin, resulting in the inhibition of microtubule depolymerization. Milataxel has completed phase II clinical trials for non-small cell lung cancer patients, and for colorectal cancer patients. Besides, it was studied for malignant mesothelioma. However, the drug has been discontinued due to toxicity issues at the dose level of 35 mg/m 2.
Originator
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6918589
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
8456
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
6918589
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
393101-41-2
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
C77880
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
PP-46
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
DTXSID40870345
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
100000178147
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107759
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
352425-37-7
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
J41Q4S20GS
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
Milataxel
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY | |||
|
DB12334
Created by
admin on Sat Dec 16 09:33:37 GMT 2023 , Edited by admin on Sat Dec 16 09:33:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY